Highlights in cardiovascular effects of histamine and H1 -receptor antagonists

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 52, Issue SUPPL. 34, 1997, Pages 67-78

  Genovese, A ^a   Spadaro, G ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Cardiac effects; H1 receptor antagonists; Histamine

Indexed keywords

ANTIFUNGAL AGENT; ASTEMIZOLE; CETIRIZINE; HISTAMINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR; LORATADINE; MACROLIDE; MAGNESIUM SULFATE; TERFENADINE;

CARDIOVASCULAR EFFECT; HEART ARRHYTHMIA; HUMAN; MAST CELL; MUSCLE CELL; PRIORITY JOURNAL; REVIEW; ULTRASTRUCTURE;

ANIMALS; CATS; CETIRIZINE; DOGS; GUINEA PIGS; HEART; HISTAMINE; HISTAMINE H1 ANTAGONISTS; HISTAMINE RELEASE; HUMANS; MYOCARDIUM; RABBITS; RATS;

EID: 0030926921     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1997.tb04813.x     Document Type: Article

References (114)

1. Patella V, Genovese A, Marone G. What are human heart mast cells for? In: Marone G ed. Human basophil and mast cells: Clinical Aspects. Basel, Karger. 1995;171-86.
2. Patella V, Marino I, Lamparter B, Arbustini E, Adt M, Marone G. Human heart mast cell. Isolation, purification, ultrastrucrure, and immunologic characterization. J Immunol 1995;154:2855-65.
3. Dvorak AM. Mast cell degranulation in human hearts. N Engl J Med 1986;315:969-70.
4. Marone G, de Crescenzo G, Adt M, Patella V, Arbustini E, Genovese A. Immunological characterization and functional importance of human heart mast cells. Immuno-pharmacol 1995;31:1-18.
5. Vigorito C, Poto S, Picotti GB, Triggiani M, Marone G. Effect of activation of the H1 receptor on coronary hemodynamics in man. Circulation 1986;73:1175-82.
6. Vigorito C, Giordano A, De Caprio L, Vitale DF, Maurea N, Silvestri P et al. Effects of histamine on coronary hemodynamics in humans: role of H1 and H2 receptors. J Am Coll Cardiol 1987;10:1207-13.
7. Marone G, Giordano A, Cirillo R, Triggiani M, Vigorito C. Cardiovascular and metabolic effects of peptide leuko-trienes in man. In: Levi R, Krell RD, eds. Biology of the leukotrienes. New York. The New York Academy of Sciences. 1988;321-33.
8. Wolff A, Levi R. Histamine and cardiac arrhythmyas. Circ Res 1986;58:1-16.
9. Levi R, Rubin LE, Gross SS. Histamine in cardiovascular function and dysfunction: recent developments. In: Uvinas B, ed. Handbook of Experimental Pharmacology. Berlin. Springer-Verlag. 1991;97:347-84.
10. Monahan BP, Ferguson CL, Killeavy ES, Lloyd BK, Troy J, Cantilena LR Jr. Torsade de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-90.
11. Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269: 1532-6.
12. Honig PK, Wortham DC, Zamani K, Conner DP, Muffin JC, Cantilena LR. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA 1993;269:1513-18.
13. Honig PK, Woosley RL, Zamani K, Conner DP, Cantilena LR Jr. Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin. Clin Pharmacol Ther 1992;52:231-8.
14. MacConnell TJ, Stanners AJ. Torsades de pointes complicating treatment with terfenadine. Br Med J 1991;302:1469 (letter).
15. Craft TM. Torsade de pointes after astemizole overdose. Br Med J 1986;292:660.
16. Snook J, Boothman-Burrell D, Watkins J, Colin-Jones D. Torsade de pointes ventricular tachycardia associated with astemizole overdose. Br J Clin Pract 1988;42:257-9.
17. Simons FER, Kesselman MS, Giddins NG, Pelech AN, Simons KJ. Astemizole-induced torsade de pointes. Lancet 1988; II: 624.
18. Rao KA, Adlakha A, Verma-Ansil B, Meloy TD, Stanton MS. Torsades de pointes ventricular tachycardia associated with overdose of astemizole. Mayo Clin Proc 1994;69:589-93.
19. Sakemi H, Van Natta B. Torsade de pointes induced by astemizole in a patient with prolongation of the QT interval. Am Heart J 1993;125:1436-8.
20. Burke TG, Mutnick AH. Ventricular fibrillation and anoxic encephalopathy secondary to astemizole overdose. Ann Pharmacother 1993;27:239-41.
21. Broadhurst P, Nathan AW. Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion. Br Heart J 1993;70:469-70.
22. Wiley JF II, Gelber ML, Henretig FM, Whey CC, Sandhu S, Loiselle J. Cardiotoxic effects of astemizole overdose in children. J Pediatr 1992;120:799-802.
23. Hoppu K, Tikanoja T, Tapanainen P, Remes M, Saarenpaa-Heikkila O, Kouvalainen K. Accidental astemizole overdose in young children. Lancet 1991;338:538-40.
24. Leor J, Harman M, Rabinowitz B, Mozes B. Giant TJ waves and associated ventricular tachycardia complicating astemizole overdose: successful therapy with intravenous magnesium. Am J Med 1991;91:94-7.
25. Tobin JR, Doyle TP, Ackerman AD, Brenner JI. Astemizole-induced cardiac conduction disturbances in a child. JAMA 1991;266:2737-40.
26. Levi R, Owen DAA, Trzeciakowskj J. Actions of histamine on the heart and vasculature. In: Ganellin CR, Parson ME, eds. Pharmacology of Histamine Receptors. London, I Wright & Sons Ltd, 1982;236-97.
27. Dale HH, Laidlaw PP. Histamine shock. J Physiol (London) 1919;52:355-90.
28. Babe KS Jr., Serafín WE. Histamine, bradikinin, and their antagonists. In: Hardman JG, Goodman Gilman A, Limbird LE, eds. The Pharmacological Basis of Therapeutics, McGraw-Hill, 1996;581-600.
29. Owen DAA. Histamine receptors in the cardiovascular system. Gen Pharmacol 1977 ;8:141-56.
30. Altura BM, Halevy S. Cardiovascular actions of histamine. In: Rocha e Silva M, ed. Handbook of experimental pharmacology. Vol. 18, part H. Histamine and antihistaminics. Berlin, Springer Verlag, 1978;1-39.
31. Folkow B, Haeger K, Kahlson G. Observations on reactive hyperaemia as related to histamine, on drugs antagonising vasodilatation induced by histamine and on vasodilator properties of adenosine triphosphate. Acta Physiol Scand 1948;15:264-78.
32. Black JW, Duncan WAM, Durant G, Ganellin CR, Parsons ME. Definition and antagonism of histamine H2-receptors. Nature 1972;236:385-90.
33. Levi R, Allan G, Zavecz HJ. Cardiac histamine receptors. Fed Proc 1976;35:1942-7.
34. Ash ASF, Schild HO. Receptors mediating some actions of histamine. Br J Pharmacol 1966;27:427-39.
35. Durant GJ, Ganellin CR, Parsons ME. Chemical differentiation of histamine H1 and H2 receptor agonists. J Med Chem 1975;18:905-9.
36. Bove AA, Dewey JD. Effects of serotonin and histamine on proximal and distal coronary vasculature in dogs: comparison with alpha-adrenergic stimulation. Am J Cardiol 1983;52:1333-9.
37. Bartlett LA. The action of histamine on the isolated heart. Br J Pharmacol Chemother 1963;21:450-61.
38. Levi R. Effects of exogenous and immunologically released histamine on the isolated heart: a quantitative comparison. J Pharmacol Exp Ther 1972;182:227-38.
39. Johnston BM, Owen DAA. Tissue blood flow and distribution of cardiac output in cats: changes caused by intravenous infusions of histamine and histamine receptor antagonists. Br J Pharmacol 1977;60:173-80.
40. Christensen CW, Gross GJ, Hardman HF, Brooks HL, Warmer DC. Effects of histamine receptor stimulation on regional myocardial blood flow. Am J Physiol 1983;245: H461-7.
41. Okpako DT. Histamine receptors in guinea pig lung vessels. Naunyn-Schmiedeberg's-Arch Pharmacol 1973; 279:35 (abstract).
42. Barer GR, Emery CJ, Mohammed FH, Mungali IPF, Thompson B. H1 and H2 histamine receptors in the pulmonary circulation. J Physiol (Lond) 1976;259:41-2.
43. Tucker A, Weir EK, Reeves JT, Grover RF. Histamine H1 and H2 receptors in pulmonary and systemic vasculature of the dog. Am J Physiol 1975;229:1008-13.
44. Levi R, Allan G Histamine mediated cardiac effects. In: Bristow M ed. Drug induced heart disease. Amsterdam, Elsevier/North Holland Biomedical Press. 1980;377-95.
45. Levi R, Pappano AJ. Modification of the effects of histamine and norepinephrine on the sinoatrial node pacemaker by potassium and calcium. J Pharmacol Exp Ther 1978; 204:625-33.
46. Levi R, Capurro N, Lee CH. Pharmacological characterization of cardiac histamine receptors: sensitivity to H1 and H2 receptor agonists and antagonists. Eur J Pharmacol 1975;30:328-35.
47. Hirschowitz BI. H2 histamine receptors. Annu Rev Pharmacol Toxicol 1979;19:203-44.
48. Reinhardt D, Wagner J, Schumann HJ. Differentiation of H1 and H2 receptors mediating positive chrono- and inotropic responses to histamine on atrial preparations of the guinea pig. Agents Actions 1974;4:217-21.
49. Levi R, Ganellin CR, Allan G, Willens HJ. Selective impairment of atrioventricular conduction by 2-(2-pyridyl)-ethylamine and 2(2-thiazolyl)- ethylamine, two histamine H1 receptor agonists. Eur J Pharmacol 1975;34:237-40.
50. Zavecz JH, Levi R. Histamine-induced negative inotro-pism: mediation by H1 receptors. J Pharmacol Exp Ther 1978;206:274-80.
51. Levi R, Kuye JO. Pharmacological characterization of cardiac histamine receptors: sensitivity to H1 receptor antagonists. Eur J Pharmacol 1974;27:330-8.
52. Reinhardt D, Wiemann HM, Schumann HJ. Effects of the H1 antagonist promethazine and the H2 antagonist buri-mamide on chronotropic, inotropic and coronary vascular responses to histamine in isolated perfused guinea pig hearts. Agents Actions 1976;6:683-9.
53. Wollemann M, Papp JG. Blockade by cimetidine of the effects of histamine on adenylate cyclase activity, spontaneous rate and contractility in the developing praenatal heart. Agents Actions 1979;9:29-30.
54. Johnson CL, Mizoguchi H. The interaction of histamine and guanylnucleotides with cardiac adenylate cyclase and its relationship to cardiac contractility. J Pharmacol Exp Ther 1977;200:174-86.
55. Zavecz JH, Levi R. Pharmacological characterization of the receptors mediating histamine induced idioventricular tachyarrhythmias. Fed Proc 1976;35:645.
56. Levi R, Zavecz JH. Acceleration of idioventricular rhythms by histamine in guinea pig heart: mediation by H2 receptors. Circ Res 1979;44:847-55.
57. Mugelli A, Mantelli L, Manzini S, Ledda F. Induction by histamine of oscillatory activity in sheep Purkinje fibers and suppression by verapamil or lidocaine. J Cardiovasc Pharmacol 1980;2:9-15.
58. Levi R, Hordof A, Edie R, Rosen MR. Histamine effects on human atria. Circulation 1978;58(Suppl II):105.
59. Levi R, Malm JR, Bowman FO, Rosen MR. The arrhythmogenic actions of histamine on human atrial fibers. Circ Res 1981;49:545-50.
60. Ginsburg R, Bristow MR, Stinson EB, Harrison DC. Histamine receptors in the human heart. Life Sci 1980;26:2245-9.
61. Eckel L, Gristwood RW, Nawrath H, Owen DAA, Satter P. Inotropic and electrophysiological effects of histamine on human ventricular heart muscle. J Physiol 1982; 330:111-23.
62. Marone G, Findlay SR, Lichtenstein LM. Adenosine receptors on human basophils: modulation of histamine release. J Immunol 1979;123:1473-7.
63. Lorenz W. Histamine release in man. Agents Actions 1975;5:402-16.
64. Wakim KG, Peters GA, Terrier JC, Hotton BT. The effects of intravenously administered histamine on the peripheral circulation in man. J Lab Clin Med 1949;34:380-6.
65. Harmer IM, Harris KE. Observations on the vascular reactions in man in response to histamine. Heart 1926;13:381-94.
66. Weiss S, Robb GP, Ellis LB. Systemic effects of histamine in man. Arch Int Med 1932;49:360-96.
67. Vigorito C, Russo P, Picotti GB, Chiariello M, Poto S, Marone G. Cardiovascular effects of histamine infusion in man. J Cardiovasc Pharmacol 1983;5:531-7.
68. Boyce MJ. Pharmacological characterization of cardiovascular histamine receptors in man in vivo. Klin Wochenschr 1982;60:978-82.
69. Owen DAA, Harvey CA, Boyce MJ. Effects of histamine on the circulatory system. Klin Wochenschr 1982;60: 972-7.
70. Kaliner M, Shelhamer JH, Ottesen EA. Effects of infused histamine: correlation of plasma histamine levels and symptoms. J Allergy Clin Immunol 1982;69:283-9.
71. Moss J, Philbin DN, Akins CW, Rosow CE, Kono K, Triantafillon A. Evaluation of and protection from morphine induced histamine release in man. Circulation 1980;62(Suppl III): 256 (abstract).
72. Duff F, Whelan RF. The effect of antihistamine substances on the responses to histamine on the blood vessels of the human forearm. Br J Pharmacol 1954;9:413-18.
73. Chipman P, Glover WE. Histamine H2-receptors in the human peripheral circulation. Br J Pharmacol 1976;56: 494-6.
74. Boyce MJ, Wareham K. Histamine H1 and H2 receptors in the cardiovascular system of man. In: Torsoli A, Lucchelli PE, Brimblecombe RW, eds. H2 antagonists. Amsterdam, Excerpta Medica 1980;280.
75. Vigorito C, Giordano A, Maurea N, Rispoli M, Casaburi E, Silvestri P et al. Histamine induced direct coronary vasodilation in man: role of H1 and H2 receptors. 10th World Congress of Cardiology, Washington. Abstract 265:1986.
76. Ginsburg R, Bristow MR, Stinson EB, Harrison DC. Histamine receptors in the human heart. Life Sci 1980; 26;2245-9.
77. Hanashiro PK, Weil MHW. Anaphylactic shock in man. Report of two cases with detailed hemodynamic and metabolic studies. Arch Intern Med 1967;119:129-40.
78. Booth BH, Patterson R. Electrocardiographic changes during human anaphylaxis. JAMA 1970;211:627-31.
79. McManus JF, Lawlor JJ. Myocardial infarction following the administration of tetanus antitoxin. New Engl J Med 1950;242:17-19.
80. Ginsburg R, Bristow MR, Kantrowitz N, Bairn DS, Harrison DC. Histamine provocation of clinical coronary artery spasm: implications concerning pathogenesis of variant angina pectoris. Am Heart J 1981;102:819-22.
81. Curry RC Jr, Pepine CJ, Sabom MB, Feldman RL, Christie LG, Conti CR. Effects of ergonovine in patients with and without coronary artery disease. Circulation 1977;56:803-9.
82. Gristwood RW, Lincoln JCR, Owen DAA. Effect of histamine on human isolated heart muscle: comparison with effects of noradrenaline. J Pharm Pharmacol 1980;32:145-6.
83. Bristow MR, Ginsburg R, Harrison DC. Histamine and the human heart: the other receptor system. Am J Cardiol 1982;49:249-51.
84. Watkins J, Dargie H, Brown M, Dollery C. Myocardial histamine H2 receptors in man. Circulation 1979;60(Suppl II): 229.
85. Bernreiter M. Electrocardiogram of patient in anaphylactic shock. JAMA 1959;170:1628-30.
86. Levi R, Capurro N. Cardiac histamine-ouabain interaction. Potentiation by ouabain of the arrhythmogenic effects of histamine. J Pharmacol Exp Ther 1975;192:113-19.
87. Simons FER, Simons KJ. The pharmacology and use of H1-receptor antagonist drugs. N Engl J Med 1994;330: 1663-70.
88. Howarth PH, Emanuel MB, Holgate ST. Astemizole, a potent histamine H1-receptor antagonist: effect in allergic rhinoconjunctivitis, on antigen and histamine induced skin weal responses and relationship to serum levels. Br J Clin Pharmacol 1984;18:1-8.
89. Juniper EF, White J, Dolovich J. Efficacy of continuous treatment with astemizole (Hismanal) and terfenadine (Seldane) in ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 1988;82:670-5.
90. Falliere CI Brandon ML, Buchman E, Connel JT, Dockhorn R, Léese PT et al. Double-blind comparison of cetirizine and placebo in the treatment of seasonal rhinitis. Ann Allergy 1991;66:257-62.
91. Del Carpio J, Kabbash L, Turenne Y, Prévost M, Hébert J, Bedard PM et al. Efficacy and safety of lorata-dine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:741-6.
92. Gibbs TG, McDonnell KA, Stokes T, Graham AA. Acrivastine in two doses compared with placebo in a multicentre, parallel group study for the treatment of seasonal allergic rhinitis. Br J Clin Pract 1989;43:11-14.
93. Brooks CD, Karl KJ, Francom SF. Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are established. Clin Exp Allergy 1990; 20:21-6.
94. Watson WTA, Simons KJ, Chen XY, Simons FER. Cetirizine: a pharmacokinetic and pharmacodynamic evaluation in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1989;84:457-64.
95. Stern MA, Rosenberg RM, Smith R, Fidler C. A comparative study of terfenadine at two dose levels in the management of hayfever. Br J Clin Pract 1990;44: 359-63.
96. Rafferty P, Holgate ST. Histamine and its antagonists in asthma. J Allergy Clin Immunol 1989;84:144-51.
97. Rafferty P, Holgate ST. Terfenadine (Seldane) is a potent and selective histamine H1-receptor antagonist in asthmatic airways. Am Rev Respir Dis 1987;135:181-4.
98. Town GI, Holgate ST. Comparison of the effect of loratadine on the airway and skin responses to histamine, methacoline, and allergen in subjects with asthma. J Allergy Clin Immunol 1990;86:886-93.
99. Brik A, Tashkin DP, Gong H Jr, Dauphinee B, Lee E. Effect of cetirizine, a new histamine H1 antagonist, on airway dynamics and responsiveness to inhaled histamine in mild asthma. J Allergy Clin Immunol 1987;80:51-6.
100. Grant JA, Bernstein DI, Buckley CE, Chu T, Fox RW, Rocklin RE et al. Double-blind comparison of terfenadine, chlorpheniramine, and placebo in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol 1988; 81:574-9.
101. Brunet C, Bedard P-M, Hebert J. Effects of H1-antihistamine drug regimen on histamine release by non-lesional skin mast cells of patients with chronic urticaria. J Allergy Clin Immunol 1990;86:787-93.
102. Cantelli T, Seidenari S, Valsecchi R, Mosca M. Double-blind comparison of astemizole and terfenadine in the treatment of chronic urticaria. Pharmatherapeutica 1986;4:679-86.
103. Belaich S, Bruttmann G, DeGreef H, Lachapelle JM, Paul E, Pedrali P et al. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Ann Allergy 1990;64:191-4.
104. Advenier C, Queille-Roussel C. Rational use of antihistamines in allergic dermatological conditions. Drugs 1989;38:634-44.
105. Berth-Jones J, Graham-Brown RAC. Failure of terfenadine in relieving the pruritus of atopic dermatitis. Br J Dermatol 1989;121:635-7.
106. Simons FER, Simons KJ. Antihistamines. In: Middleton E Jr, Reed CE, Ellis EF, Adkinson NF Jr, Yunginger JW, Busse WW, eds Allergy: principles and practice. 4th ed. Vol.1. St Louis Mosby-Year Book, 1993;856-92.
107. Goldberg MJ, Spector R, Chiang CK. Transport of diphenhydramine in the central nervous system. J Pharmacol Exp Ther 1987;240:717-22.
108. Meltzer EO. Comparative safety of H1 antihistamines. Ann Allergy 1991;67:625-33.
109. Simons FER. H1-receptor antagonists. Comparative tolerability and safety. Drug Safety 1994;10:350-80.
110. Goetz DW, Jacobson JM, Apaliski SJ, Repperger DW, Martin ME. Objective antihistamine side effects are mitigated by evening dosing of hydroxyzine. Ann Allergy 1991;67:448-54.
111. Alford C, Rombaut N, Jones J, Foley S, Idzikowski C, Hindmarch I. Acute effects of hydroxyzine on nocturnal sleep and sleep tendency the following day: a C-EEG study. Hum Psychopharmacol 1992;7:25-35.
112. Seidel WF, Cohen S, Bliwise NG, Dement WC. Direct measurement of daytime sleepiness after administration of cetirizine and hydroxyzine with a standardized electro-encephalographic assessment. J Allergy Clin Immunol 1990;86:1029-33.
113. Bhatti JZ, Hindmarch I. The effects of terfenadine with and without alcohol on an aspect of car driving performance. Clin Exp Allergy 1989;19:609-11.
114. Bradley CM, Nicholson AN. Studies on the central effects of the H1-antagonist, loratadine. Eur J Clin Pharmacol 1987;32:419-21.